UCLA - The Jules Stein Eye Institute Trials

UCLA - The Jules Stein Eye Institute	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Aldave, Anthony J

PUTT, NCT06213649: Parasitic Ulcer Treatment Trial

Recruiting

232

Europe, US, RoW

Polyhexamethylene biguanide (PHMB), Polyhexanide, Topical corticosteroid, Topical placebo

Jeremy Keenan, MD, MPH, Johns Hopkins University, Oregon Health and Science University, University of Illinois at Chicago, University of Michigan, University of California, Los Angeles, University of Miami, University of Pennsylvania, Columbia University, University of Iowa, University of Florida, Aravind Eye Care System, Moorfields Eye Hospital NHS Foundation Trust, Federal University of São Paulo, National Eye Institute (NEI)

Acanthamoeba Keratitis

07/28

EXPEDE, NCT04081103: NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries

Terminated

Nexagon® (lufepirsen) High Dose Concentration, Nexagon® (lufepirsen) Low Dose Concentration, Vehicle, Placebo, Open-label Nexagon® (lufepirsen)

Amber Ophthalmics, Inc.

Corneal Persistent Epithelial Defect

02/22

ExCrossV, NCT06753916: Multi Site Trial for Vascularized High Risk Keratoplasty

Not yet recruiting

Corneal Donor Tissue with Cross Linking, Treatment, Corneal Donor Tissue without Cross Linking, Control

Massachusetts Eye and Ear Infirmary

Corneal Transplant Failure

01/28

01/31

NCT04627571: Corneal Nerves After Treatment With Cenegermin

Active, not recruiting

N/A

Cenegermin Ophthalmic Solution [Oxervate]

University of California, Los Angeles, Dompé Farmaceutici S.p.A

Neurotrophic Keratitis

02/25

Pascual, Ellen